Peptonic Medical

Peptonic Medical is a publicly traded Swedish company leading in the non-prescription, clinically proven intimate self-care market. Founded in 2009, it commercializes a portfolio of non-hormonal, additive-free products for conditions such as vaginal atrophy under its VagiVital and Vernivia brands. The company employs a hybrid business model of direct-to-consumer sales and B2B white-label partnerships, with subsidiaries in the USA supporting its global expansion. Recent leadership changes and the termination of its liquidity guarantee agreement indicate a period of strategic transition.

Proprietary formulations for non-hormonal, additive-free topical products for vaginal health, supported by a global IP portfolio focused on intimate self-care.

Peptonic competes with other OTC intimate care brands, prescription therapies for vaginal atrophy, and general wellness products. Its key differentiation is its focus on 'clinically proven' non-hormonal formulations, positioning it against both pharmaceutical companies and consumer goods giants entering the femtech sector.